Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix

S. B. Donaldson, D. L. Buckley, J. P. O'Connor, S. E. Davidson, B. M. Carrington, A. P. Jones, C. M L West

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background: There is a need for simple imaging parameters capable of predicting therapeutic outcome.Methods: This retrospective study analysed 50 patients with locally advanced carcinoma of the cervix who underwent dynamic contrast-enhanced MRI before receiving potentially curative radiotherapy. The proportion of enhancing pixels (E F) in the whole-tumour volume post-contrast agent injection was calculated and assessed in relation to disease-free survival (DFS).Results: Tumours with high E F had a significantly poorer probability of DFS than those with low E F (P0.011).Interpretation:E F is a simple imaging biomarker that should be studied further in a multi-centre setting. © 2010 Cancer Research UK All rights reserved.
    Original languageEnglish
    Pages (from-to)23-26
    Number of pages3
    JournalBritish Journal of Cancer
    Volume102
    Issue number1
    DOIs
    Publication statusPublished - Jan 2010

    Keywords

    • Cervix cancer
    • Dynamic contrast-enhanced MRI
    • Enhancing fraction
    • Imaging biomarkers
    • Radiotherapy

    Fingerprint

    Dive into the research topics of 'Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix'. Together they form a unique fingerprint.

    Cite this